The drug development company has launched a Community Stakeholder Initiative that allows more people to invest in next-generation empathogens. The post...
Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical-stage natural psychedelic drug development company, today announced the distribution...
Universal Ibogaine (TSX.V: IBO), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered...
Some analysts have called the industry's business model problematic. The post Despite Psychedelic Industry Buzz, Some Have Crashed Already appeared first...
Source: Andrew Partheniou 12/20/2022 The company, focused on psychedelic-assisted psychotherapies to better treat addiction, is worth more...
The article Gilgamesh Pharmaceuticals Raises $39 Million in Series B Financing was originally published on Microdose. Gilgamesh Pharmaceuticals has announced...
Sensorium Therapeutics, a biotechnology company leveraging medicinal chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive...
Let’s get straight to it: The psychedelic stock market continues to underperform. Taking a look at our Psychedelic Invest Index, we can see that only...
The drug development company inspires psychedelics experts, but struggles to raise funds for its ketamine-assisted therapies and addiction treatments. The...
Awaken Life Sciences is trying to ride out a tough market for investment capital and raise funds for its ketamine-assisted therapies and addiction treatments. The...